30489611Sherman SK, Lange JJ, Dahdaleh FS, Rajeev R, Gamblin TC, Polite BN, Turaga KKJAMA oncologyAntineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colorectal Neoplasms; Drug CostsAged; Cost-Benefit Analysis; Disease Progression; Female; Humans; Maintenance Chemotherapy; Male; Markov Chains; Medicare; Middle Aged; Models, Economic; Neoplasm Metastasis; Quality of Life; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; United StatesCost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer. JAMA Oncol. 2019 02 01; 5(2):236-242.JAMA Oncol2019-02-01T00:00:002019Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000368Living Beings1341183530.294764AgedD000971Procedures30624340.476235Antineoplastic Combined Chemotherapy ProtocolsD003362Activities & BehaviorsConcepts & Ideas2224500.810631Cost-Benefit AnalysisAuthorship 1244836Authorship 1244840.3498330.1749162authors10.2523has subject areaD006278Concepts & IdeasProcedures1584040.75834MedicareD008390Concepts & Ideas801250.954228Markov ChainsD008875Concepts & IdeasLiving Beings1473249570.258811Middle AgedD005260Physiology1992444050.191167FemaleD011788Concepts & Ideas43115750.549258Quality of LifeD006801Living Beings2262862810.130052HumansD013997Concepts & Ideas118351980.519628Time FactorsD014481Geographic Areas102566370.406601United StatesD008297Physiology1931408600.201617MaleD016032Concepts & IdeasProcedures2778500.730116Randomized Controlled Trials as TopicMedicine-Hematology and OncologyD016527Concepts & Ideas42620.924763Drug CostsD016896Concepts & Ideas101179490.402389Treatment OutcomeD009362Disorders26910560.715963Neoplasm MetastasisD018450Physiology49815310.700842Disease ProgressionD019057Concepts & Ideas601380.927957Quality-Adjusted Life YearsD015179Disorders1989240.568531Colorectal NeoplasmsD018803Concepts & Ideas45600.955649Models, EconomicD000068258732810.891431BevacizumabD00006928742950.952268CapecitabineD060046Procedures34760.954647Maintenance ChemotherapyUniversity of ChicagoBlasePoliteBlase Polite41.78927490000000-87.60125000000000891Polite, BlaseProfessortrue1ProfessorProfessor